Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-22-007001

Options or other derivatives

  • Director acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
CARTER BRUCE L A Director 2022-03-03 Grant or award · Stock Option (right to buy) +7,500 7,500 D: show line 1 in the form
Loading xslF345X03/form4.xml…